Risk-Based HCC Surveillance Strategies Using HCC Risk Prediction Models Have Greater Net Benefit Than the Current "One-Size-Fits-All" Strategy In Patients who Received Antiviral Treatment for HCV

Conference Reports for NATAP

The Liver Meeting
San Francisco
November 2018


Risk-Based HCC Surveillance Strategies Using HCC Risk Prediction Models Have Greater Net Benefit Than the Current "One-Size-Fits-All" Strategy In Patients who Received Antiviral Treatment for HCV

	Reported by Jules Levin AASLD 2018 Nov 9-13 SF